NovoCure (NVCR) Launches 12.5M Common Stock IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
NovoCure Limited (NVCR) IPO Opens Lower
October 2, 2015 10:43 AM EDTToday's IPO for NovoCure Limited (Nasdaq: NVCR) opened for trading at $20.16 after pricing 12,500,000 shares of its common stock at $22, below the $23-$24 revised IPO range. Shares last traded at $19.
J.P. Morgan Securities LLC, Deutsche Bank Securities and Evercore Group... More
NovoCure (NVCR) Trims IPO Expectations
October 1, 2015 2:10 PM EDTNovoCure Ltd. (Nasdaq: NVCR) filed an amended registration with the U.S. SEC today. The company now plans to offer 7.5 million ordinary shares and sees an offering price of $23 - $24 per share, from prior expectations of offering 12.5 million shares with an expected pricing... More
